PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $974,000 | +162.5% | 300,000 | +154.1% | 0.00% | +200.0% |
| Q2 2019 | $371,000 | -83.1% | 118,046 | -87.8% | 0.00% | -90.0% |
| Q1 2017 | $2,200,000 | +173.3% | 969,050 | +303.2% | 0.01% | +150.0% |
| Q3 2016 | $805,000 | -69.2% | 240,320 | -23.5% | 0.00% | -75.0% |
| Q1 2014 | $2,612,000 | -53.7% | 314,303 | -53.0% | 0.02% | -52.9% |
| Q4 2013 | $5,640,000 | -32.1% | 668,228 | -35.9% | 0.03% | -35.8% |
| Q3 2013 | $8,308,000 | +29.0% | 1,042,428 | +25.0% | 0.05% | +26.2% |
| Q2 2013 | $6,439,000 | – | 834,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |